Impairments of neural circuit function in Alzheimer’s disease

Marc Aurel Busche, Arthur Konnerth

Research output: Contribution to journalReview articlepeer-review

214 Scopus citations


An essential feature of Alzheimer’s disease (AD) is the accumulation of amyloid-β (Aβ) peptides in the brain, many years to decades before the onset of overt cognitive symptoms. We suggest that during this very extended early phase of the disease, soluble Aβ oligomers and amyloid plaques alter the function of local neuronal circuits and large-scale networks by disrupting the balance of synaptic excitation and inhibition (E/I balance) in the brain. The analysis of mouse models of AD revealed that an Aβ -induced change of the E/I balance caused hyperactivity in cortical and hippocampal neurons, a breakdown of slow-wave oscillations, as well as network hypersynchrony. Remarkably, hyperactivity of hippocampal neurons precedes amyloid plaque formation, suggesting that hyperactivity is one of the earliest dysfunctions in the pathophysiological cascade initiated by abnormal Aβ accumulation. Therapeutics that correct the E/I balance in early AD may prevent neuronal dysfunction, widespread cell loss and cognitive impairments associated with later stages of the disease. This article is part of the themed issue ‘Evolution brings Ca2+ and ATP together to control life and death’.

Original languageEnglish
Article number20150429
JournalPhilosophical Transactions of the Royal Society B: Biological Sciences
Issue number1700
StatePublished - 5 Aug 2016


  • Alzheimer’s disease
  • Amyloid-β
  • In vivo calcium imaging
  • Mouse models


Dive into the research topics of 'Impairments of neural circuit function in Alzheimer’s disease'. Together they form a unique fingerprint.

Cite this